These review results were mixed on the use of immunotherapy to treat narcolepsy, with benefits typically being temporary. The chronic sleep disorder narcolepsy is characterized by excessive daytime ...
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the ...
Nearly a decade on from the 2009 influenza pandemic, scientists are still trying to solve what is proving to be an intractable medical mystery: Did some of the vaccines used to protect against the new ...
ZURICH, SWITZERLAND / ACCESSWIRE / March 27, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin ...
There is currently no cure for narcolepsy. However, some natural treatments and lifestyle adjustments may help people manage symptoms. Narcolepsy is a rare sleep disorder that causes people to fall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results